Trial intelligence / Profile preview

FARE Method in Pertrochanteric Fracture Proximal Femoral Nail Osteosynthesis

NCT06135298Phase 4Completed

Sponsor
Aksaray University
Start
Dec 2023
Primary completion
Jul 2025
Countries
1
01

Overview

Phase 4, randomised, open-label trial in osteoporosis and Pertrochanteric fracture (ITF) (2 arms), sponsored by Aksaray University. Primary endpoints: Change of bone density around the helical blade of proximal femoral nail at 6 months and Bone remodeling around the helical blade of proximal femoral nail at 6 months. Started Dec 2023; status: completed.

02

Conditions

osteoporosisPertrochanteric fracture (ITF)

Beyond the preview

Go deeper on NCT06135298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06135298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call